In the USA, every year, 150,000 patients die and 1.5 million develop a medical complication after surgery 1 . As postoperative complications cause a twofold increase in 30-day mortality and incur an annual cost of US$25 billion, even a small reduction in their occurrence could save lives and reduce health-care costs 2 . Acute kidney injury (AKI) occurs in up to 30% of patients following surgery and is associated with an increased risk of other major complications as well as increased health-care costs. Postoperative AKI that does not resolve promptly is associated with the development of chronic critical illness, chronic kidney disease and permanent dis ability [3] [4] [5] . Now, the INPRESS study, a multicentre, prospective, parallel-group clinical trial conducted in nine French hospitals, reports that a personalized perioperative blood pressure management strategy reduced the risk of postoperative organ dysfunction, including AKI, in high-risk patients 6 . The risk of postoperative complications arises from the complex interaction between the preoperative health status of the patient and their organ-specific physiological capa city to withstand surgery-related stress. In addition, the type and quality of the surgery and anaesthesia that the patient undergoes modulate the risk. Patients in good health, with high organ-specific physiological reserve, survive even high-risk procedures associated with with hypertension may need higher perfusion pressures during surgery. No consensus exists, however, regarding optimal blood pressure targets to support perfusion of critical organs during surgery. As a result, both systolic blood pressure (SBP) and mean arterial blood pressure thresholds, as well as the type and dose of drugs (fluids and vaso pressors) used to achieve these thresholds, vary widely in practice.
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The INPRESS study included 298 high-risk patients aged ≥50 years who were undergoing major surgery (of an expected duration of ≥2 h) under general anaesthesia 6 . Participants were randomly assigned to either an individualized or a standard blood pressure management strategy during and for 4 h following surgery. The aim of the individualized strategy was to achieve a SBP within 10% of the reference value (the resting SBP of the patient) using a titration protocol for continuous infusion of noradrenaline, whereas the standard management strategy used intravenous ephedrine administered in 6 mg boluses (with a maximum dose of 60 mg) for any decrease in SBP of <80 mmHg or to <40% of the reference value. The primary outcome was a composite of systemic inflammatory response syndrome (SIRS) and dysfunction of at least one organ within 7 days after surgery: AKI diagnosed using RIFLE (risk, injury, failure, loss of function and end-stage renal disease) criteria, respiratory dysfunction (defined by the need for invasive or non-invasive mechanical ventilation), cardiovascular events (cardiac ischaemia or failure), neurological dysfunction (stroke or Glasgow Coma Scale ≤14) and coagulation (platelet count <100,000).
The individualized intervention resulted in a 14% decrease (95% CI −25% to −2%) in the absolute risk of the primary outcome. By postoperative day seven, 38.1% of patients with individualized SBP management experi enced the primary outcome compared with 51.7% of those who received standard management. The incidences of renal dysfunction defined as RIFLE stage R or higher (32.7% versus 49%) and of neuro logi cal complications (5.4% versus 15.9%) were significantly lower in the individualized management group than in the standard management group, but no between-group differences were reported in the incidence of SIRS or of other organ dysfunction. Importantly, the lower incidence of acute stresses -such as haemodynamic instability due to blood loss, prolonged hypoperfusion of major organs, inflammation and drug toxicity -and may not have any substantial postoperative organ dysfunction. By contrast, patients in poor health with low organ-specific physiological reserve might experience substantial organ dysfunction even after minor surgery. Optimal perioperative care, therefore, requires personalized management to minimize the effects of the acute stress of surgery and anaesthesia, informed by precise and timely identification of patients at the greatest risk of individual complications.
Intraoperative hypotension is a wellrecognized risk factor for multiple postoperative complications, including AKI. Moreover, in patients with hypertension, the autoregulatory capacity of the kidneys and other organs can be impaired, which may render them susceptible to injury at blood pressures that for normotensive patients would be considered appropriate. As such, patients
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Standardized prevention approaches can decrease the incidence of acute kidney injury among high-risk patients. Now, the INPRESS study demonstrates that a personalized intraoperative blood pressure management strategy guided by risk stratification can improve perioperative practice and reduce the risk of organ dysfunction among high-risk patients undergoing major surgery. the lower incidence of renal dysfunction was the result of a lower incidence of RIFLE stage R AKI only renal dysfunction was the result of a lower incidence of RIFLE stage R AKI only; no between-group differences were reported in the incidences of more severe AKI categories or in the use of renal replacement therapy. By postoperative day 30, patients in the individualized treatment group had less overall organ dysfunction (adjusted HR 0.66; P = 0.001) and a lower incidence of sepsis (adjusted relative risk 0.54; P = 0.009) than those in the standard group; however, no significant betweengroup difference in all-cause mortality was reported.
A strength of the INPRESS study is that risk assessment, beyond that of the standard American Society of Anesthesiologists (ASA) physical status classification (which relies solely on an assessment of preoperative comorbidities), was used to assure a homogeneous cohort of patients. In addition, the researchers used a sophisticated perioperative protocol in which they discontinued specific hypertensive medications 24 hours before surgery and standardized anaesthesia induction, fluid management and ventilator management. Some variations from current US practice (the use of hydroxyethylstarch for fluid boluses and liberal transfusion triggers) don't detract from the validity of the findings.
To identify patients at increased risk of postoperative complications for enrolment in the study, the researchers used the AKI risk index, which was developed in a retrospective analysis of the National Surgical Quality Improvement Program (NSQIP) database 7 . However, this index is an insensitive logistic regression model that predicts only the 1% of patients undergoing surgery who will develop very severe AKI (the incidence of all stages of RIFLE AKI in the INPRESS cohort was 40%). As the primary outcome of INPRESS was not AKI but rather a composite of SIRS and one major organ dysfunction, and no betweengroup difference was reported in the incidence of RIFLE stage F AKI, the use of the AKI risk index as an enrichment tool is questionable.
This study offers a window into a new mode of practice by demonstrating that personalized intraoperative management can improve outcomes. Mounting evidence suggests that standardized prevention strategies -based on published consensus guidelines and applied to patients identified at high risk of AKI -can decrease the incidence of surgery-associated AKI 4, 8, 9 . Although studies to date have not demonstrated a mortality benefit of such strategies, the emerging message is clear: a combination of existing clinical, biological and imaging studies can be used to standardize perioperative management and thus reduce the incidence of AKI and other complications. The INPRESS investigators have added a personalized tool to our arsenal of preventive strategies for patients at risk for surgery-associated complications. The next step is to incorporate real-time data streams and analyses into the type of personalized perioperative approach used in the INPRESS study. We recommend a large platform clinical trial, using real-time perioperative analytics as well as current practice guidelines, to advance our ability to prevent surgical complications 10 (FIG. 1) .
